DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prolia (Denosumab) - Current Clinical Trials

 
 



Prolia Related Clinical Trials

Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Prolia� in Routine Clinical Practice [Completed]

Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia� in France [Recruiting]

Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density [Completed]

Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip Arthroplasty [Recruiting]

A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density [Completed]

AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Patients With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment [Active, not recruiting]

Denosumab in Primary Hyperparathyroidism [Completed]

Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP [Recruiting]

Denosumab Administration After Spinal Cord Injury [Recruiting]

Denosumab for Breast Cancer With Bone Mets [Recruiting]

Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo [Active, not recruiting]

Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation [Recruiting]

Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders [Not yet recruiting]

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks [Recruiting]

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma [Not yet recruiting]

Effects of Denosumab Therapy for Japanese [Recruiting]

Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous Dose [Completed]

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab [Recruiting]

Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women [Recruiting]

Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients [Active, not recruiting]

The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam [Completed]

Anakinra or Denosumab and Everolimus in Advanced Cancer [Recruiting]

Denosumab for Treating Periprosthetic Osteolysis. [Not yet recruiting]

Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates [Completed]

Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis [Completed]

A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis [Completed]

RA Denosumab on Bone Microstructure Study [Completed]

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer [Active, not recruiting]

Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis [Completed]

Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid Arthritis [Completed]

Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer [Completed]

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass [Completed]

Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy [Recruiting]

The Efficacy of Denosumab in Active Crohn's Disease [Not yet recruiting]

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer [Active, not recruiting]

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone [Completed]

A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects [Completed]

Phase II Trial of Ra-223 Dichloride and Hormonal Treatment [Recruiting]

Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis [Completed]

Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer [Recruiting]

Effect of RANKL Inhibition on UV-induced Immunosuppression [Completed]

Study of Denosumab in Subjects With Giant Cell Tumor of Bone [Recruiting]

Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate Cancer [Completed]

Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty [Active, not recruiting]

Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab [Completed]

A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors [Active, not recruiting]

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium [Completed]

A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis [Active, not recruiting]

Longjohn Amgen Study - Effect of Denosumab... [Not yet recruiting]

A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab [Completed]

A Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids [Active, not recruiting]

Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis [Active, not recruiting]

Effects of Denosumab on the Pharmacokinetics of Etanercept [Recruiting]

Denosumab and Teriparatide Study (DATA-2) [Recruiting]

Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index [Recruiting]

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density [Completed]

Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120mg in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis [Completed]

Denosumab Adherence Preference Satisfaction Study [Completed]

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. [Completed]

Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. [Recruiting]

A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density. [Completed]

A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab [Completed]

Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis [Active, not recruiting]

Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis [Completed]

Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OI [Recruiting]

Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis [Completed]

Study of Transitioning From Alendronate to Denosumab [Completed]

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease [Withdrawn]

A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab [Completed]

An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density [Completed]

A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates [Completed]

TNFSF11 Inhibition and Fertility: a Prospective Study [Recruiting]

A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab [Completed]

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer [Completed]

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. [Completed]

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy [Active, not recruiting]

Estimation of Off-Label Use of XGEVA� (Denosumab) Using Population-Based Databases in Denmark [Completed]

Study to Evaluate the Safety and Efficacy of Denosumab and Actonel� in Post Menopausal Women Transitioned From Alendronate Therapy [Completed]

Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients [Recruiting]

Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis [Completed]

Safety Assessment Among Women With Postmenopausal Osteoporosis and Men With Osteoporosis in Multiple Observational Databases [Recruiting]

A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy [Active, not recruiting]

A Double-Blind, Randomized, Single-Dose, Parallel-Group Study in Healthy Volunteers to Assess the Bioequivalence of a 120 mg Denosumab Subcutaneous Dose When Administered as Denosumab CP4 Drug Product or as Commercially Available Denosumab CP2 Drug Product [Completed]

Denosumab China Phase III Study [Active, not recruiting]

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer [Completed]

Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer [Completed]

Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab [Completed]

AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer [Completed]

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer [Completed]

Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption [Recruiting]

Open Label Extension to SRE Studies in United Kingdom and Czech Republic Only [Completed]

Survey of XGEVA Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw [Completed]

Observational Study of Prolia in Postmenopausal Women With Osteoporosis [Active, not recruiting]

China HVT Safety, PK, PD [Completed]

Effect of Amgen Investigational Product on Cellular Biomarkers in the Human Breast [Completed]

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017